Prenetics Global Limited (PRENW)
PRENW Stock Price Chart
Explore Prenetics Global Limited interactive price chart. Choose custom timeframes to analyze PRENW price movements and trends.
PRENW Company Profile
Discover essential business fundamentals and corporate details for Prenetics Global Limited (PRENW) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
—
Employees
285.00
Website
https://www.prenetics.comCEO
Sheng Wu Yeung
Description
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
PRENW Financial Timeline
Browse a chronological timeline of Prenetics Global Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 12 Jun 2025
EPS came in at -$0.80 surpassing the estimated -$0.80 by +0.12%, while revenue for the quarter reached $17.31M , beating expectations by +44.27%.
PRENW Stock Performance
Access detailed PRENW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.